-
Lenvatinib, sold
under the
brand name
Lenvima among others, is an anti-cancer
medication for the
treatment of
certain kinds of
thyroid cancer and for other...
- baricitinib, cabozantinib, dasatinib, neratinib, eltrombopag, ibrutinib,
lenvatinib, palbociclib, regorafenib, tofacitinib, and trelagliptin.
BEACON Medicare...
-
breast cancer Iomeron (iomeprol) - Non-ionic
contrast medium Lenvima (
lenvatinib) -
Thyroid Cancer or
Kidney Cancer Leqembi (lecanemab) - Alzheimer's disease...
-
Kinase inhibitors:
Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
-
after resection, or to
relieve pain from bone metastasis.
Sorafenib and
lenvatinib are
approved for
advanced metastatic thyroid cancer.
Numerous agents are...
- triple-negative
breast cancer Avalglucosidase alfa
Genzyme late-onset
Pompe disease Lenvatinib Eisai Inc
advanced renal cell carcinoma, used in
combination with pembrolizumab...
-
Kinase inhibitors:
Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
-
Kinase inhibitors:
Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
-
Kinase inhibitors:
Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
-
Kinase inhibitors:
Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
